泰格医药

- 300347

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
泰格医药(300347) 利润表
单位:万元
报表日期2022-06-302022-03-312021-12-312021-09-302021-06-30
一、营业总收入359,420.92181,785.90521,353.81339,501.52205,637.49
营业收入359,420.92181,785.90521,353.81339,501.52205,637.49
二、营业总成本259,701.13133,963.48363,776.48228,670.80137,422.02
营业成本216,733.33111,201.14294,288.30180,729.19107,820.43
营业税金及附加854.75349.982,253.691,570.211,125.17
销售费用8,003.973,851.3612,939.929,584.976,665.60
管理费用31,365.0915,894.6754,748.0338,864.8824,576.60
财务费用-8,308.03-3,032.45-21,636.31-17,559.02-12,069.16
研发费用11,052.015,698.7821,182.8615,480.579,303.39
资产减值损失----------
公允价值变动收益41,327.6412,513.11181,538.97111,734.3790,608.30
投资收益8,644.565,555.3331,228.2912,517.3511,256.22
其中:对联营企业和合营企业的投资收益3,555.59--1,434.82--72.33
汇兑收益----------
三、营业利润148,092.0365,438.13369,696.69234,084.18169,700.64
加:营业外收入407.98173.29632.65243.30155.61
减:营业外支出513.4811.191,872.76737.15578.23
其中:非流动资产处置损失----------
四、利润总额147,986.5265,600.23368,456.58233,590.34169,278.02
减:所得税费用16,223.928,203.1829,286.3615,018.2210,353.35
五、净利润131,762.6057,397.05339,170.22218,572.11158,924.67
归属于母公司所有者的净利润119,200.4051,841.68287,416.30178,105.01125,497.85
少数股东损益12,562.205,555.3751,753.9240,467.1033,426.82
六、每股收益
基本每股收益(元/股)1.38000.60003.31002.05001.4400
稀释每股收益(元/股)1.38000.60003.30002.04001.4400
七、其他综合收益18,483.39-252.26-8,991.81-3,319.94-4,402.45
八、综合收益总额150,245.9957,144.79330,178.41215,252.17154,522.22
归属于母公司所有者的综合收益总额133,402.1451,787.12281,018.36175,927.47122,086.05
归属于少数股东的综合收益总额16,843.855,357.6749,160.0539,324.7032,436.17
下载全部历史数据到excel中 返回页顶